How Viruses Enter and Hide in the Brain

Neurotropic Viral Persistence: Mechanisms of Invasion, Latency, and Chronic Neuropathogenesis

Benjamin Aaron Gustafsson AdultCognitiveDisease.com

---

1. Introduction: The Central Nervous System as a Viral Ecological Niche

The Central Nervous System (CNS), comprised of the brain and spinal cord, has traditionally been conceptualized as an immune-privileged sanctuary, physically sequestered from the systemic circulation by the Blood-Brain Barrier (BBB) and chemically insulated from the robust immune surveillance that characterizes peripheral tissues. This architectural isolation, evolved to protect non-regenerative neuronal networks from potentially destructive inflammatory responses, paradoxically renders the CNS a distinct and highly specialized ecological niche for a specific subset of pathogens: neurotropic viruses.

The query regarding which viruses can live in the brain and why is not merely a question of cataloging pathogens; it requires a fundamental dissection of the molecular interplay between viral evolution and neural architecture. "Living" in the brain encompasses two distinct biological phenomena: acute invasion with high-titer replication (as seen in Rabies or Japanese Encephalitis) and long-term persistence or latency, where the virus establishes a chronic residency, often lasting the lifetime of the host (as seen in Herpesviruses or Measles SSPE).

Recent research has dismantled the binary notion of the BBB as an impenetrable wall, revealing it instead as a dynamic interface that neurotropic viruses have evolved to unlock, bypass, or breach. Furthermore, the discovery of the glymphatic system—a macroscopic waste-clearance system utilizing perivascular tunnels formed by astroglial cells—has fundamentally altered our understanding of CNS immunology, suggesting that the brain is far more interacting with the peripheral immune system than previously believed.¹

This report provides an exhaustive analysis of the viral agents capable of infiltrating the CNS, the specific cellular and molecular mechanisms they employ to traverse the BBB, the sophisticated strategies utilized to establish latency, and the downstream consequences of this persistence, ranging from acute encephalitis to chronic neurodegenerative conditions such as Multiple Sclerosis (MS) and Amyotrophic Lateral Sclerosis (ALS).

2. The Architecture of Invasion: Breaching the

Blood-Brain Barrier

The primary obstacle to viral infection of the brain is the blood-brain barrier (BBB), a highly selective semipermeable border of endothelial cells. These cells are stitched together by tight junctions (TJs) composed of proteins such as occludin, claudins, and zonula occludens-1 (ZO-1), which effectively restrict paracellular diffusion of hydrophilic molecules and pathogens. For a virus to establish a foothold in the CNS, it must first negotiate this formidable defense using one of three primary strategies: paracellular entry (breaking the barrier), transcellular transport (moving through the cell), or the "Trojan Horse" mechanism (hitching a ride). 2.1 The "Trojan Horse" Mechanism: Hijacking Immune Mobility One of the most insidious methods of neuroinvasion involves the infection of circulating leukocytes—monocytes, macrophages, or T cells—which naturally possess the ability to traverse the BBB during immune surveillance or inflammation. This strategy, known as the "Trojan Horse" mechanism, effectively camouflages the virus from the endothelial defenses. This is a primary route for Retroviruses like Human Immunodeficiency Virus (HIV) and Human T-lymphotropic virus 1 (HTLV-1).³ In the context of HIV, the virus targets CD4 and CCR5 receptors on monocytes and macrophages. Under normal physiological conditions, these cells can cross the BBB to conduct surveillance. However, when infected, these cells not only transport the viral payload into the brain parenchyma but also secrete viral proteins (such as Tat and gp120) and inflammatory cytokines that further compromise BBB permeability.⁵ This creates a self-perpetuating cycle: the entry of the first infected cells triggers a local inflammatory response, attracting more immune cells, which in turn brings more virus into the protected space. This mechanism is not exclusive to retroviruses. Emerging evidence suggests that arboviruses, including West Nile Virus (WNV) and Zika Virus (ZIKV), may also utilize the diapedesis of infected immune cells to access the CNS.⁶ In cases of severe Dengue virus infection, the recruitment of immune cells to the CNS, ostensibly to fight the infection, inadvertently increases the viral load within the parenchyma.⁸ 2.2 Transcellular Transport: Receptor-Mediated Endocytosis Some viruses possess the specific molecular keys to unlock the endothelial cells of the BBB themselves. This occurs via transcytosis, where virions are endocytosed on the luminal (blood-facing) side of the endothelial cell and exocytosed on the abluminal (brain-facing) side without necessarily replicating within the endothelial cell itself.⁶ Flaviviruses are particularly adept at this. West Nile Virus (WNV) and Japanese Encephalitis Virus (JEV) can directly infect endothelial cells or pass through them via receptor-mediated endocytosis. The efficiency of this transport is often dictated by the expression of specific adhesion molecules. For instance, WNV entry is facilitated by αvβ3 integrin and DC-SIGN receptors, which are expressed on the surface of microvascular endothelial cells.⁹ The virus exploits these receptors, which physiologically function in cell adhesion and signaling, to trick the cell into internalizing the viral particle. 2.3 Paracellular Entry: Degrading the Tight Junctions The third mechanism involves the physical disruption of the tight junctions that seal the BBB. This is rarely a passive process; rather, it is often an active result of the "cytokine storm" induced by systemic infection. Pro-inflammatory cytokines, particularly Tumor Necrosis Factor-alpha (TNF-α), Interleukin-1 beta (IL-1β), and Interleukin-6 (IL-6), are potent downregulators of TJ proteins. When a virus like the Mouse Hepatitis Virus (a coronavirus model) or highly virulent strains of Influenza infect the host, the resulting systemic immune response leads to a downregulation of ZO-1 and occludin.¹¹ This "loosens" the endothelial seal, allowing viral particles to diffuse between cells (paracellularly) into the CNS. Furthermore, Matrix Metalloproteinases (MMPs) play a critical, destructive role in this process. MMPs are enzymes capable of degrading the extracellular matrix and junctional proteins. During severe viral infections, MMP expression is upregulated, directly digesting the structural components of the BBB.¹¹ Interestingly, the host has counter-mechanisms; signaling via Interferon-beta (IFN-β) and TAM receptors (Tyro3, Axl, Mer) serves to stabilize endothelial tight junctions and enhance barrier integrity.¹¹ Thus, the integrity of the BBB during viral infection is a dynamic equilibrium between viral-induced cytokine damage (MMPs, TNF-α) and host-mediated repair signals (IFNs, TAMs). 2.4 Retrograde Axonal Transport: The Neural Highway Certain neurotropic viruses bypass the BBB entirely by infecting peripheral nerve endings and utilizing the host's own transport machinery to travel inside the axons to the CNS. This is the hallmark mechanism of the Rabies virus (RABV), Poliovirus, and Herpes Simplex Virus (HSV).¹³ Rabies virus enters motor neurons at the neuromuscular junction. It binds to nicotinic acetylcholine receptors (nAChR) or the Neural Cell Adhesion Molecule (NCAM), enters the axon, and associates with the dynein motor complex. Dynein is the cellular motor responsible for retrograde transport (moving cargo toward the cell body). RABV effectively hijacks this system, traveling along microtubules to the neuronal soma in the spinal cord and brainstem.¹⁴ This transport is not merely passive; the binding of RABV to the p75 neurotrophin receptor (p75NTR) may accelerate this retrograde transport, allowing the virus to reach the CNS with remarkable speed.¹⁶ 3. Neuroinvasion Strategies by Viral Family The specificity of neurotropism—why a virus targets the brain and not the lungs, or specific neurons and not astrocytes—is dictated by the presence of viral entry receptors on CNS cells. The following analysis breaks down the specific mechanisms employed by major neurotropic viral families. 3.1 Flaviviridae: WNV, JEV, and Zika The Flaviviruses are primarily arboviruses (arthropod-borne) that have evolved efficient mechanisms to invade the vertebrate CNS. They are responsible for a significant burden of viral encephalitis worldwide.

● Japanese Encephalitis Virus (JEV): JEV is strictly neurotropic and causes severe

inflammation. A key mechanistic insight into JEV pathogenesis is its exploitation of the dopaminergic system. Research indicates that JEV infection leads to elevated dopamine levels, which in turn enhances viral entry into cells expressing the Dopamine D2 Receptor (D2R).¹⁸ This explains the virus's specific tropism for the midbrain and striatum, regions rich in dopaminergic neurons. By mimicking physiological ligands or exploiting the signaling cascades of dopamine, JEV gains access to the neuronal cytoplasm. Additionally, JEV can enter cells via GRP78 (BiP), a heat shock protein overexpressed on the surface of stressed cells.¹⁹ ● West Nile Virus (WNV): WNV demonstrates a capacity for long-term persistence, particularly in the kidneys and CNS, even in immunocompetent individuals. This persistence is associated with chronic symptoms such as memory loss and weakness.²⁰ WNV can persist in the CNS of mice for up to 6 months post-infection, suggesting that what is often termed "recovery" may actually be a transition to a low-level chronic infection.²¹

● Zika Virus (ZIKV): The 2015-2016 Zika epidemic highlighted a novel form of

neurotropism: the targeting of Neural Progenitor Cells (NPCs). Unlike other flaviviruses that target mature neurons, ZIKV preferentially infects developing NPCs, leading to cell cycle arrest and apoptosis, which manifests clinically as congenital microcephaly.²² While initial studies implicated the AXL receptor as the primary entry gate, subsequent in vivo models (Axl knockout mice) showed that AXL is not essential for replication, suggesting the existence of redundant entry pathways or alternative receptors like Tyro3.²³ Furthermore, ZIKV degrades perineuronal nets (PNNs) in neonates, structures critical for synaptic stabilization, which may lead to neurodevelopmental deficits even in the absence of gross morphological defects like microcephaly.²² 3.2 Paramyxoviridae: Rabies, Measles, and Nipah This family includes some of the most lethal neurotropic viruses, characterized by distinct transport and fusion mechanisms.

● Rabies Virus (RABV): RABV is the archetype of neuroinvasion. Its "living" in the brain is

characterized by a stealthy replication strategy. Unlike JEV or WNV, which cause massive apoptosis and inflammation, RABV preserves the neuronal network it infects. This is crucial for its evolutionary strategy: to alter host behavior (aggression) to facilitate transmission. If the virus killed the host neurons too quickly, the host would become paralyzed and unable to bite, ending the transmission chain.²⁶ The virus travels bi-directionally in peripheral neurons (anterograde and retrograde) but shifts to exclusively retrograde transport to reach the CNS.¹⁴

● Measles Virus (MeV): While acute measles is a respiratory and systemic infection, the

virus can establish a persistent, fatal infection in the brain known as Subacute Sclerosing Panencephalitis (SSPE). This occurs years after the initial infection. The mechanism of SSPE is a profound example of viral evolution within the host. The virus that persists in the brain is distinct from the wild-type virus; it is defective. Specifically, it harbors hypermutations in the Matrix (M) protein gene that prevent viral assembly and budding.²⁸ Because it cannot bud, it cannot be neutralized by antibodies in the extracellular space. Instead, it spreads directly from neuron to neuron using a hyperfusogenic Fusion (F) protein and host Cell Adhesion Molecules (CADM1 and CADM2) as receptors.³⁰ This "cis-acting" fusion mechanism allows the virus to creep through the brain parenchyma, hidden inside the cells, slowly destroying the CNS. 3.3 Coronaviridae: SARS-CoV-2 The neurotropism of SARS-CoV-2 is a subject of intense investigation. While the virus clearly causes neurological sequelae ("brain fog," anosmia, stroke), frank viral encephalitis is rarer than with other neurotropic viruses.

● The NRP1 Gateway: The primary receptor for SARS-CoV-2, ACE2, is expressed at very

low levels in the brain parenchyma, making direct infection of neurons via this route inefficient. However, Neuropilin-1 (NRP1) has been identified as a critical cofactor. NRP1 is expressed in the olfactory epithelium and arguably in CNS tissues, where it enhances viral entry by binding to the furin-cleaved Spike protein.³²

● Indirect Neuropathology: Evidence suggests that much of the "living" presence of

SARS-CoV-2 in the brain context refers to the lingering effects of inflammation rather than active viral replication. The virus may disrupt the BBB via endothelial infection or cytokine storms, leading to leakage of blood-borne components that trigger neuroinflammation. Recent models indicate that neuronal infection, while possible, induces a massive recruitment of leukocytes and BBB dysfunction, which drives the pathology.³⁴ 3.4 Polyomaviridae: JC Virus The JC Virus (JCV) is a ubiquitous human pathogen, infecting the majority of the population and establishing latency in the kidneys and bone marrow. It is benign in healthy individuals but lethal in the immunocompromised, where it causes Progressive Multifocal Leukoencephalopathy (PML).

● Receptor Specificity: JCV is unique in its tropism for oligodendrocytes, the

myelin-producing cells of the CNS. Its entry is facilitated by the 5-HT2A serotonin receptor.³⁶ This finding is clinically significant because it suggests that serotonin receptor antagonists (like the antidepressant Mirtazapine) could theoretically block viral entry. The virus uses 5-HT2A as an entry receptor in conjunction with the carbohydrate LSTc. This specific receptor usage explains why the virus destroys white matter (myelin) specifically, leading to the demyelinating symptoms of PML. 3.5 Alphaviruses: VEEV and EEEV Alphaviruses such as Venezuelan Equine Encephalitis Virus (VEEV) and Eastern Equine Encephalitis Virus (EEEV) represent distinct threats. EEEV is highly lethal but humans are often "dead-end hosts," meaning the virus replicates in the brain, killing the host, but does not develop high enough titers in the blood to be picked up by a mosquito for transmission to a new host.³⁸ ● Aerosol Transmission: VEEV is notable for its potential to infect via aerosolization, bypassing the BBB via the olfactory nerve. In macaque models, VEEV demonstrates a biphasic fever, with neurological signs appearing in the second phase. Crucially, the virus can persist in the brain and lymph nodes for weeks after the acute phase, driven by the infiltration of T lymphocytes and activated microglia.³⁹ 3.6 Retroviridae: HIV and HTLV-1 Retroviruses are masters of persistence, integrating their genetic material directly into the host genome.

● HIV-1: HIV enters the CNS early in infection, often within weeks. It does not typically

infect neurons directly due to their lack of CD4 receptors. Instead, it establishes a reservoir in perivascular macrophages and microglia.⁴⁰

● Astrocyte Infection: While microglia are the primary productive reservoir, astrocytes

play a critical, complex role. They can be infected via a mechanism involving cell-to-cell contact with infected lymphocytes. Immature virions bud off lymphocytes and bind to CXCR4 receptors on astrocytes, triggering fusion even in the absence of CD4.⁴² Although this infection is often non-productive (the virus enters but doesn't always replicate efficiently), the sheer number of astrocytes in the brain makes them a significant viral sink and a contributor to neuroinflammation.

Table 1: Key Receptors and Mechanisms of Viral Entry into the CNS

Virus Family Specific Virus Primary CNS Entry Receptors /

Target Cells Mechanisms

Flaviviridae Japanese Neurons Dopamine D2

Encephalitis (JEV) (Dopaminergic) Receptor (D2R), GRP78 ¹⁸ West Nile Virus Neurons, Glia DC-SIGN, αvβ3 (WNV) integrin ⁹ Zika Virus (ZIKV) Neural Progenitor AXL (controversial), Cells (NPCs) Tyro3, TAM kinases ²³ Coronaviridae SARS-CoV-2 Endothelial cells, ACE2 (low in brain), Neurons (?) Neuropilin-1 (NRP1) ³²

Paramyxoviridae Measles Virus Neurons, CD150 (SLAM -

(SSPE) Astrocytes absent on neurons), CADM1/2 (cis-acting fusion) ³⁰ Rabies Virus Neurons (Motor) nAChR, NCAM, (RABV) p75NTR (axonal transport) ¹⁶

Polyomaviridae JC Virus (JCV) Oligodendrocytes 5-HT2A Serotonin

Receptor, LSTc ³⁶

Retroviridae HIV-1 Microglia, CD4, CCR5, CXCR4

Astrocytes ⁴¹

Alphaviridae VEEV Neurons, Glia LDL receptor class

A domain (LDLRAD) (putative), Olfactory entry ³⁹ 4. The Mechanics of Latency: The "Stay and Hide"

Phase

Once inside the CNS, viruses must avoid clearance. In peripheral tissues, infected cells are rapidly destroyed by cytotoxic T lymphocytes (CTLs). However, neurons are post-mitotic and non-renewable. The immune system is evolutionarily hesitant to destroy neurons, as this would result in permanent neurological deficit. Consequently, viruses have evolved molecular switches to enter dormancy or latency within these protected cells. 4.1 Herpesviridae: The Masters of Neuronal Latency Herpes Simplex Virus 1 (HSV-1) and Varicella Zoster Virus (VZV) are the paradigmatic examples of neurotropic latency. Following primary infection in epithelial cells (lip or skin), these viruses travel retrograde to sensory ganglia—the Trigeminal Ganglia (TG) for HSV and the Dorsal Root Ganglia (DRG) for VZV—where they establish lifelong latency.⁴⁴

● Molecular Regulation of HSV Latency: In the neuronal nucleus, the HSV genome

circularizes and associates with host histones, effectively becoming a mini-chromosome. The lytic genes (required for making new virus) are repressed. The only abundant viral transcript during this period is the Latency-Associated Transcript (LAT). The LAT is a non-coding RNA that functions as an epigenetic regulator. It promotes the accumulation of heterochromatin (tightly packed DNA) on viral lytic promoters, specifically via histone H3 lysine 9 methylation (H3K9me2/3).⁴⁶ This effectively silences the virus.

● Reactivation: The virus can reactivate when "stress" signals alter the neuronal

environment. This involves the viral protein ICP0, which acts as a transactivator to reverse the epigenetic silencing. Reactivation sends the virus back down the axon to the periphery, causing a cold sore.

● VZV and Enteric Latency: VZV latency is distinct. While it resides in the DRG, recent

evidence proves it also establishes latency in the autonomic nervous system, specifically the Enteric Nervous System (ENS) of the gut.⁴⁸ This "enteric zoster" can cause gastric pain and complications without the characteristic skin rash. Furthermore, VZV reactivation is temperature-sensitive; lower temperatures (34°C) enhance reactivation, which may explain its preference for skin (which is cooler than the core) during replication.⁴⁹ 4.2 Measles and SSPE: A Defective Variant As introduced in Section 3.2, Subacute Sclerosing Panencephalitis (SSPE) is caused by a persistent Measles Virus infection. The persistence mechanism here is not true latency (silence) but rather a "smoldering" infection.

● The Matrix Protein Defect: The SSPE virus is characterized by a breakdown in the

interaction between the viral Matrix (M) protein and the nucleocapsid. In wild-type measles, M proteins line the cell membrane to orchestrate the budding of the virus. In SSPE, hypermutations render the M protein unstable or non-functional.²⁸ The virus cannot leave the cell.

● Cis-Acting Fusion (The "Crawler"): Trapped inside the neuron, the virus adapts by

mutating its Fusion (F) protein. It acquires the ability to trigger fusion with neighboring cells using the host protein CADM1 or CADM2. Crucially, recent research identifies that specific "short stalk" isoforms of CADM1 are required for this interaction.⁵¹ The interaction occurs in cis—meaning the viral protein and the host receptor interact on the same cell membrane to trigger fusion with the adjacent cell.³¹ This allows the viral genome (RNP) to pass directly from one neuron to the next through the fusion pore, never entering the extracellular space. This renders neutralizing antibodies completely useless, as they cannot reach the intracellular virus. 4.3 HIV: The Proviral Reservoir HIV persistence in the brain is distinct because it involves the integration of the viral DNA (provirus) into the host genome of microglia and macrophages. ● Microglial Longevity: Microglia are extremely long-lived cells, capable of self-renewal. Once HIV integrates into a microglial cell, that cell becomes a permanent reservoir.

● Compartmentalization: The virus within the CNS often evolves independently from the

virus in the blood. This "compartmentalized" virus can develop distinct genetic traits, such as macrophage-tropism (using CCR5) rather than T-cell tropism.⁴¹ This poses a major challenge for cure strategies, as drugs that clear the virus from the blood may not effectively penetrate the BBB to reach the distinct CNS reservoir.⁵² 5. Immunopathology and the Myth of Immune

Privilege

Historically, the CNS was considered "immune privileged," a concept suggesting it was ignored by the immune system. We now know this is incorrect. The CNS is immunologically specialized, not ignored. This specialization, however, contributes to viral persistence. 5.1 The Glymphatic System and Antigen Drainage The glymphatic system clears metabolic waste and soluble proteins from the CNS, draining them into the meningeal lymphatic vessels and subsequently to the deep cervical lymph nodes.¹ This pathway allows the immune system to "sample" CNS antigens. While this enables immune surveillance, it also provides a route for viral dissemination. Conversely, the flow of cerebrospinal fluid (CSF) can carry inflammatory cytokines throughout the brain, turning a local infection into global neuroinflammation. 5.2 T-Cell Exhaustion In chronic CNS infections, the immune system faces a dilemma: if it attacks infected neurons too aggressively, it will cause brain damage. To prevent this, T cells infiltrating the brain often undergo "exhaustion."

● Mechanism: Exhaustion is a state of T-cell dysfunction characterized by the expression

of inhibitory receptors like PD-1 and TIM-3, and reduced production of cytokines like IFN-γ and TNF-α. This state is driven by continuous antigen stimulation.⁵³ ● The Double-Edged Sword: In models like Lymphocytic Choriomeningitis Virus (LCMV), T-cell exhaustion is necessary to prevent lethal immunopathology. Mice that do not develop exhausted T cells often die from severe brain inflammation. However, this exhaustion effectively prevents the clearance of the virus, allowing it to persist indefinitely.⁵⁵ The virus exploits this "truce" to remain in the host. 5.3 Immune Privilege as a Reservoir The "immune privilege" sites—the eyes, the testes, and the CNS—can serve as sanctuaries for viruses even after they have been cleared from the rest of the body. This was dramatically illustrated during the Ebola outbreaks, where EBOV persisted in the intraocular fluid and the CNS of survivors long after recovery from acute disease.⁵⁶ The mechanisms involve the blood-retina and blood-brain barriers, which block the entry of antibodies, and the local expression of immunosuppressive molecules (like TGF-β) that inhibit T-cell function. 6. Chronic Sequelae: Neurodegeneration and

Autoimmunity

The persistence of viruses in the brain is increasingly recognized as a driver of chronic neurodegenerative diseases, challenging the traditional view that conditions like MS and ALS are purely genetic or idiopathic. 6.1 Multiple Sclerosis (MS) and Viral Triggers Two viral families are heavily implicated in MS: Herpesviruses (specifically EBV) and Endogenous Retroviruses (HERVs).

● Epstein-Barr Virus (EBV): Infection with EBV is now considered a prerequisite for

developing MS. The leading mechanistic hypothesis involves "molecular mimicry." Antibodies produced against the EBV nuclear antigen 1 (EBNA1) have been found to cross-react with GlialCAM, a protein expressed in the CNS.⁵⁸ This autoimmune attack damages the myelin sheath. Furthermore, EBV-infected B cells can infiltrate the MS brain and form "ectopic lymphoid follicles" in the meninges, creating a local factory for autoreactive antibodies and T cells that perpetuate the disease.⁶⁰

● HERV-W (MSRV): The Multiple Sclerosis-associated Retrovirus (MSRV), a member of the

HERV-W family, is frequently expressed in MS lesions. The MSRV Envelope (Env) protein acts as a superantigen. It binds to Toll-like Receptor 4 (TLR4) on microglia and macrophages, triggering a potent release of pro-inflammatory cytokines that leads to oligodendrocyte death and demyelination.⁶² This represents a reactivation of a "fossil" virus residing in our own genome. 6.2 Amyotrophic Lateral Sclerosis (ALS) and HERV-K In ALS, a similar mechanism is observed with HERV-K (HML-2).

● TDP-43 Regulation: In healthy neurons, the protein TDP-43 binds to retroviral elements

in the genome to keep them silenced. In ALS, TDP-43 becomes dysfunctional and aggregates in the cytoplasm. This loss of nuclear TDP-43 function leads to the de-repression of HERV-K.⁶⁴

● Neurotoxicity: The reactivated HERV-K produces an Envelope protein that is transported

to the neuronal cell membrane. This protein is neurotoxic and causes the degeneration of motor neurons, leading to the paralysis characteristic of ALS. Transgenic mice expressing HERV-K Env develop motor dysfunction similar to ALS ⁶⁴, providing strong evidence for causality.

Table 2: Viral Associations with Chronic Neurodegenerative Conditions

Condition Associated Virus Mechanism of Key

Pathogenesis Biomarkers/Findin gs

Multiple Sclerosis Epstein-Barr Virus Molecular Mimicry EBNA1 antibodies;

(MS) (EBV) (EBNA1 vs. EBER+ B-cells in

GlialCAM); Ectopic meninges ⁵⁹ Lymphoid Follicles HERV-W (MSRV) Superantigen MSRV Env protein activation of TLR4; in lesions; Elevated Pro-inflammatory HERV-W RNA ⁶² cytokine storm

ALS HERV-K (HML-2) TDP-43 HERV-K Env

dysfunction leads expression in to viral reactivation; cortical neurons; Env protein TDP-43 aggregates neurotoxicity ⁶⁴

Post-Polio Poliovirus Chronic Deterioration of Syndrome inflammation; motor units

Persistence of viral decades after fragments? infection ⁶⁶ (Debated)

Progressive JC Virus (JCV) Lytic infection of 5-HT2A receptor

Multifocal oligodendrocytes usage; LSTc

Leukoencephalop causing binding ³⁶ athy (PML) demyelination

7. Evolutionary Implications: Why Target the Brain? Why do viruses evolve to enter the brain? For many viruses, the brain is a "dead-end." Infections like EEEV or WNV in humans often result in host death or fail to produce sufficient viremia to infect a mosquito vector, meaning the virus cannot spread further. These are "spillover" events, accidents of biology where a virus adapted for birds or horses encounters a human.³⁸ However, for some viruses, neurotropism is a specific, evolved survival strategy. 7.1 Behavioral Manipulation: The Rabies Strategy Rabies virus is the ultimate example of adaptive neurotropism. It does not merely infect the brain; it targets the limbic system (controlling aggression) and the salivary glands simultaneously.

● Survival of the Host: Unlike EEEV which kills quickly, Rabies keeps the host alive and

mobile during the infectious phase. It inhibits apoptosis (programmed cell death) in the infected neurons to preserve the neural circuits required for biting behavior.²⁶

● Aggression: By inducing aggression and hydrophobia (preventing swallowing of

saliva-laden virus), it maximizes the chances of transmission to a new host. This is a sophisticated manipulation of host biology for viral propagation. 7.2 Viruses as Drivers of Brain Evolution In a twist of evolutionary irony, the very complexity of the mammalian brain may be due to ancient viral infections.

● The Arc Gene: The neuronal gene Arc, which is essential for synaptic plasticity and

memory formation, is structurally homologous to the Gag protein of retroviruses. It forms virus-like capsids that transfer RNA between neurons, a mechanism likely repurposed from an ancient retroviral infection.⁶⁸

● KRAB Zinc Fingers: The expansion of the primate brain has been linked to the "arms

race" between the genome and endogenous retroviruses. The host evolved KRAB zinc finger proteins to suppress viral promoters. In doing so, these repressors also began regulating endogenous neuronal genes, inadvertently driving the evolution of complex neural networks.⁶⁹ Thus, the viruses that plague the brain today are distant cousins of the viruses that helped build it. 8. Therapeutic Implications and Future Outlook Understanding the mechanisms of viral persistence in the brain opens new avenues for treatment, moving beyond broad-spectrum antivirals.

1. Blocking Cis-Acting Fusion: For diseases like SSPE, traditional neutralizing antibodies are ineffective. However, small molecule inhibitors targeting the specific interaction between the mutated Measles F protein and CADM1 could halt the "creeping" spread of the virus between neurons.⁷⁰
2. Reversing T-Cell Exhaustion: In chronic infections, checkpoint inhibitors (like anti-PD-1) could theoretically reinvigorate the immune response to clear the virus. However, this carries the high risk of inducing fatal autoimmune encephalitis, requiring a delicate balance.⁷¹
3. Targeting HERVs in Neurodegeneration: Clinical trials using antiretroviral drugs (originally designed for HIV) are currently underway for ALS patients to suppress HERV-K activity. If successful, this would fundamentally reclassify ALS as a treatable viral-mediated condition.⁷²
4. Glymphatic Modulation: Enhancing glymphatic flow could potentially help clear viral antigens and inflammatory mediators from the CNS, offering a supportive therapy for post-viral syndromes.
5. Conclusion The ability of viruses to "live" in the brain is a testament to their evolutionary plasticity. They do not merely assault the fortress of the central nervous system; they pick its locks. They mimic dopamine to enter reward centers, hijack motor proteins to travel up axons, and exploit the brain's own immune privilege to hide from surveillance. The data elucidated in this report underscores that viral persistence is not a passive accident but an active, molecularly regulated state. From the histone modifications silencing HSV to the matrix protein defects of SSPE, viruses have evolved specific "programs" for neuronal residency. Furthermore, the emerging links between these persistent pathogens and catastrophic neurodegenerative diseases like MS and ALS suggest that the burden of neurotropic viral infection extends far beyond acute encephalitis. The brain, once thought to be a sterile sanctuary, is increasingly revealed as a reservoir of latent viral ghosts, whose reactivation may dictate the trajectory of neurological health and disease.

Works cited

1. Zou K, Deng Q, Zhang H, Huang C. Glymphatic system: a gateway for neuroinflammation. Neural Regen Res 2024;19(12):2661-2672. DOI 10.4103/1673-5374.391312.

2. Mogensen FL, Delle C, Nedergaard M. The Glymphatic System (En)during Inflammation. Int J Mol Sci 2021;22(14). DOI 10.3390/ijms22147491.

3. Neurotropic virus - Wikipedia, accessed November 19, 2025, https://en.wikipedia.org/wiki/Neurotropic_virus

4. Verma AK, Perlman S. Unraveling the complexities of neurotropic virus infection and immune evasion. Microbiology and Molecular Biology Reviews 2025;89(3). DOI 10.1128/mmbr.00185-23.

5. Viral Infection and the Blood-Brain Barrier: Molecular Research Insights and Therapies | The Journal of Infectious Diseases | Oxford Academic, accessed November 19, 2025, https://academic.oup.com/jid/advance-article/doi/

   Find this paper

6. Ayala-Nunez NV, Gaudin R. A viral journey to the brain: Current considerations and future developments. PLoS Pathog 2020;16(5):e1008434. DOI 10.1371/journal.ppat.1008434.

7. Chen Z, Li G. Immune response and blood-brain barrier dysfunction during viral neuroinvasion. Innate Immun 2021;27(2):109-117. DOI 10.1177/1753425920954281.

8. The Blood-Brain Barrier in Infectious Disease: Pathogenic Mechanisms and Therapeutic Strategies | Frontiers Research Topic, accessed November 19, 2025, https://www.frontiersin.org/research-topics/8027/the-blood-brain-barrier-in-infe ctious-disease-pathogenic-mechanisms-and-therapeutic-strategies/magazine

9. Martin M, Nisole S. West Nile Virus Restriction in Mosquito and Human Cells: A Virus under Confinement. Vaccines 2020;8(2):256. DOI 10.3390/vaccines8020256.

10. West Nile Virus Discriminates between DC-SIGN and DC-SIGNR for Cellular

Davis CW, Nguyen H, Hanna SL, Sánchez MD, Doms RW, Pierson TC. West Nile Virus Discriminates between DC-SIGN and DC-SIGNR for Cellular Attachment and Infection. Journal of Virology 2006;80(3):1290-1301. DOI 10.1128/jvi.80.3.1290-1301.2006.

11. Miner JJ, Diamond MS. Mechanisms of restriction of viral neuroinvasion at the blood-brain barrier. Curr Opin Immunol 2016;38:18-23. DOI 10.1016/j.coi.2015.10.008.

12. Nipah Virus Neurotropism: Insights into Blood-Brain Barrier Disruption - IMR Press, accessed November 19, 2025, https://www.imrpress.com/journal/JIN/23/5/

13. Uribe FR, González VPI, Kalergis AM, Soto JA, Bohmwald K. Understanding the Neurotrophic Virus Mechanisms and Their Potential Effect on Systemic Lupus Erythematosus Development. Brain Sci 2024;14(1). DOI 10.3390/brainsci14010059.

14. Bauer A, Nolden T, Schröter J, Römer-Oberdörfer A, Gluska S, Perlson E, et al.. Anterograde Glycoprotein-Dependent Transport of Newly Generated Rabies Virus in Dorsal Root Ganglion Neurons. Journal of Virology 2014;88(24):14172-14183. DOI 10.1128/jvi.02254-14.

15. Tan GS, Preuss MAR, Williams JC, Schnell MJ. The dynein light chain 8 binding motif of rabies virus phosphoprotein promotes efficient viral transcription. Proceedings of the National Academy of Sciences 2007;104(17):7229-7234. DOI 10.1073/pnas.0701397104.

16. Gluska S, Zahavi EE, Chein M, Gradus T, Bauer A, Finke S, et al.. Rabies Virus Hijacks and Accelerates the p75NTR Retrograde Axonal Transport Machinery. PLoS Pathogens 2014;10(8):e1004348. DOI 10.1371/journal.ppat.1004348.

17. Engagement of Neurotropic Viruses in Fast Axonal Transport: Mechanisms, Potential Role of Host Kinases and Implications for Neuronal Dysfunction - Frontiers, accessed November 19, 2025, https://www.frontiersin.org/journals/cellular-neuroscience/articles/ 021.684762/full

18. Japanese Encephalitis Virus Exploits Dopamine D2 Receptor-phospholipase C to Target Dopaminergic Human Neuronal Cells - Frontiers, accessed November 19, 2025, https://www.frontiersin.org/journals/microbiology/articles/ 51/full

    Find this paper

19. Yadav P, Chakraborty P, Jha NK, Dewanjee S, Jha AK, Panda SP, et al.. Molecular Mechanism and Role of Japanese Encephalitis Virus Infection in Central Nervous System-Mediated Diseases. Viruses 2022;14(12). DOI 10.3390/v14122686.

20. Murray K, Walker C, Herrington E, Lewis JA, McCormick J, Beasley DW, et al.. Persistent infection with West Nile virus years after initial infection. J Infect Dis 2010;201(1):2-4. DOI 10.1086/648731.

21. Appler KK, Brown AN, Stewart BS, Behr MJ, Demarest VL, Wong SJ, et al.. Persistence of West Nile virus in the central nervous system and periphery of mice. PLoS One 2010;5(5):e10649. DOI 10.1371/journal.pone.0010649.

22. Editorial: Cellular and molecular mechanisms of neurotropic viral infection - Frontiers, accessed November 19, 2025, https://www.frontiersin.org/journals/cellular-neuroscience/articles/ 024.1365755/full

23. Zika virus differentially infects human neural progenitor cells according to their state of differentiation and dysregulates neurogenesis through the Notch

Ferraris P, Cochet M, Hamel R, Gladwyn-Ng I, Alfano C, Diop F, et al.. Zika virus differentially infects human neural progenitor cells according to their state of differentiation and dysregulates neurogenesis through the Notch pathway. Emerg Microbes Infect 2019;8(1):1003-1016. DOI 10.1080/22221751.2019.1637283.

24. Nowakowski TJ, Pollen AA, Di Lullo E, Sandoval-Espinosa C, Bershteyn M, Kriegstein AR. Expression Analysis Highlights AXL as a Candidate Zika Virus Entry Receptor in Neural Stem Cells. Cell Stem Cell 2016;18(5):591-6. DOI 10.1016/j.stem.2016.03.012.

25. Li F, Wang PR, Qu LB, Yi CH, Zhang FC, Tang XP, et al.. AXL is not essential for Zika virus infection in the mouse brain. Emerg Microbes Infect 2017;6(3):e16. DOI 10.1038/emi.2017.10.

26. Yu X, Zhu Y, Yin G, Wang Y, Shi X, Cheng G. Exploiting hosts and vectors: viral strategies for facilitating transmission. EMBO Rep 2024;25(8):3187-3201. DOI 10.1038/s44319-024-00214-6.

27. Davis BM, Rall GF, Schnell MJ. Everything You Always Wanted to Know About Rabies Virus (But Were Afraid to Ask). Annu Rev Virol 2015;2(1):451-71. DOI 10.1146/annurev-virology-100114-055157.

28. Satoh Y, Higuchi K, Nishikawa D, Wakimoto H, Konami M, Sakamoto K, et al.. M protein of subacute sclerosing panencephalitis virus, synergistically with the F protein, plays a crucial role in viral neuropathogenicity. J Gen Virol 2021;102(10). DOI 10.1099/jgv.0.001682.

29. Cathomen T, Mrkic B, Spehner D, Drillien R, Naef R, Pavlovic J, et al.. A matrix‐less measles virus is infectious and elicits extensive cell fusion: consequences for propagation in the brain. The EMBO Journal 1998;17(14):3899-3908. DOI 10.1093/emboj/17.14.3899.

30. Schmitz KS, Handrejk K, Liepina L, Bauer L, Haas GD, van Puijfelik F, et al.. Functional properties of measles virus proteins derived from a subacute sclerosing panencephalitis patient who received repeated remdesivir treatments. Journal of Virology 2024;98(3). DOI 10.1128/jvi.01874-23.

31. Shirogane Y, Takemoto R, Suzuki T, Kameda T, Nakashima K, Hashiguchi T, et al.. CADM1 and CADM2 Trigger Neuropathogenic Measles Virus-Mediated Membrane Fusion by Acting in cis. Journal of Virology 2021;95(14). DOI 10.1128/jvi.00528-21.

32. Davies J, Randeva HS, Chatha K, Hall M, Spandidos DA, Karteris E, et al.. Neuropilin‑1 as a new potential SARS‑CoV‑2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID‑19. Mol Med Rep 2020;22(5):4221-4226. DOI 10.3892/mmr.2020.11510.

33. Mayi BS, Leibowitz JA, Woods AT, Ammon KA, Liu AE, Raja A. The role of Neuropilin-1 in COVID-19. PLOS Pathogens 2021;17(1):e1009153. DOI 10.1371/journal.ppat.1009153.

34. SARS-CoV-2 infection of the brain: the K18-hACE2 mouse model to illustrate the role and response of the vasculature in neurotropic viral infection | bioRxiv, accessed November 19, 2025, DOI 10.1101/2025.02.07.637145">https://www.biorxiv.org/content/10.1101/2025.02.07.637145

35. Lopes TRR, Sitton BS, Pillat MM, Mello CF, Weiblen R, Flores EF, et al.. SARS-CoV-2 and neurotropism: evidence, gaps and reflections. J Med Microbiol 2025;74(6). DOI 10.1099/jmm.0.002016.

36. Maginnis MS, Haley SA, Gee GV, Atwood WJ. Role of N-linked glycosylation of the 5-HT2A receptor in JC virus infection. J Virol 2010;84(19):9677-84. DOI 10.1128/JVI.00978-10.

37. Deadly Eastern Equine Encephalitis Virus Is a Familiar but Formidable Foe, accessed November 19, 2025,

https://hms.harvard.edu/news/deadly-eastern-equine-encephalitis-virus-familiarformidable-foe

39. Ma H, Albe JR, Gilliland T, McMillen CM, Gardner CL, Boyles DA, et al.. Long-term persistence of viral RNA and inflammation in the CNS of macaques exposed to aerosolized Venezuelan equine encephalitis virus. PLOS Pathogens 2022;18(6):e1009946. DOI 10.1371/journal.ppat.1009946.

40. Wallet C, De Rovere M, Van Assche J, Daouad F, De Wit S, Gautier V, et al.. Microglial Cells: The Main HIV-1 Reservoir in the Brain. Front Cell Infect Microbiol 2019;9:362. DOI 10.3389/fcimb.2019.00362.

41. Gumbs SBH, Kübler R, Gharu L, Schipper PJ, Borst AL, Snijders GJLJ, et al.. Human microglial models to study HIV infection and neuropathogenesis: a literature overview and comparative analyses. J Neurovirol 2022;28(1):64-91. DOI 10.1007/s13365-021-01049-w.

42. Li GH, Henderson L, Nath A. Astrocytes as an HIV Reservoir: Mechanism of HIV Infection. Curr HIV Res 2016;14(5):373-381. DOI 10.2174/1570162x14666161006121455.

43. Strange DP, Jiyarom B, Pourhabibi Zarandi N, Xie X, Baker C, Sadri-Ardekani H, et al.. Axl Promotes Zika Virus Entry and Modulates the Antiviral State of Human Sertoli Cells. mBio 2019;10(4). DOI 10.1128/mbio.01372-19.

44. Nicoll MP, Proença JT, Efstathiou S. The molecular basis of herpes simplex virus latency. FEMS Microbiol Rev 2012;36(3):684-705. DOI 10.1111/j.1574-6976.2011.00320.x.

45. Cohen JI. VZV: molecular basis of persistence (latency and reactivation). Human Herpesviruses 2007:689-699. DOI 10.1017/cbo9780511545313.039.

46. Jiang X, Chentoufi AA, Hsiang C, Carpenter D, Osorio N, BenMohamed L, et al.. The herpes simplex virus type 1 latency-associated transcript can protect neuron-derived C1300 and Neuro2A cells from granzyme B-induced apoptosis and CD8 T-cell killing. J Virol 2011;85(5):2325-32. DOI 10.1128/JVI.01791-10.

47. Wang Q, Zhou C, Johnson KE, Colgrove RC, Coen DM, Knipe DM. Herpesviral latency-associated transcript gene promotes assembly of heterochromatin on viral lytic-gene promoters in latent infection. Proceedings of the National Academy of Sciences 2005;102(44):16055-16059. DOI 10.1073/pnas.0505850102.

48. Varicella-Zoster Virus and the Enteric Nervous System | The Journal of Infectious Diseases, accessed November 19, 2025, https://academic.oup.com/jid/article/218/suppl_2/S113/5105956

49. Markus A, Lebenthal-Loinger I, Yang IH, Kinchington PR, Goldstein RS. An In Vitro Model of Latency and Reactivation of Varicella Zoster Virus in Human Stem Cell-Derived Neurons. PLOS Pathogens 2015;11(6):e1004885. DOI 10.1371/journal.ppat.1004885.

50. Patterson JB, Cornu TI, Redwine J, Dales S, Lewicki H, Holz A, et al.. Evidence that the hypermutated M protein of a subacute sclerosing panencephalitis measles virus actively contributes to the chronic progressive CNS disease. Virology 2001;291(2):215-25. DOI 10.1006/viro.2001.1182.

51. Takemoto R, Suzuki T, Hashiguchi T, Yanagi Y, Shirogane Y. Short-Stalk Isoforms of CADM1 and CADM2 Trigger Neuropathogenic Measles Virus-Mediated Membrane Fusion by Interacting with the Viral Hemagglutinin. J Virol 2022;96(3):e0194921. DOI 10.1128/JVI.01949-21.

Takemoto R, Suzuki T, Hashiguchi T, Yanagi Y, Shirogane Y. Short-Stalk Isoforms of CADM1 and CADM2 Trigger Neuropathogenic Measles Virus-Mediated Membrane Fusion by Interacting with the Viral Hemagglutinin. Journal of Virology 2022;96(3). DOI 10.1128/jvi.01949-21.

52. Nühn MM, Gumbs SBH, Schipper PJ, Drosou I, Gharu L, Buchholtz NVEJ, et al.. Microglia Exhibit a Unique Intact HIV Reservoir in Human Postmortem Brain Tissue. Viruses 2025;17(4). DOI 10.3390/v17040467.

53. Mueller SN, Ahmed R. High antigen levels are the cause of T cell exhaustion during chronic viral infection. Proceedings of the National Academy of Sciences 2009;106(21):8623-8628. DOI 10.1073/pnas.0809818106.

54. T Cell Exhaustion - Annual Reviews, accessed November 19, 2025, https://www.annualreviews.org/content/journals/ 2-110914

55. Kahan SM, Wherry EJ, Zajac AJ. T cell exhaustion during persistent viral infections. Virology 2015;479-480:180-93. DOI 10.1016/j.virol.2014.12.033.

56. Rivera A, Messaoudi I. Molecular mechanisms of Ebola pathogenesis. J Leukoc Biol 2016;100(5):889-904. DOI 10.1189/jlb.4RI0316-099RR.

57. Wong G, Qiu X, Bi Y, Formenty P, Sprecher A, Jacobs M, et al.. More Challenges From Ebola: Infection of the Central Nervous System. J Infect Dis 2016;214(suppl 3):S294-S296. DOI 10.1093/infdis/jiw257.

58. Study identifies how Epstein-Barr virus triggers multiple sclerosis - Stanford Medicine, accessed November 19, 2025, https://med.stanford.edu/news/all-news/2022/01/epstein-barr-virus-multiple-scle rosis.html

59. New study explains how a common virus can cause multiple sclerosis | Karolinska Institutet, accessed November 19, 2025, https://news.ki.se/new-study-explains-how-a-common-virus-can-cause-multiple -sclerosis

60. Serafini B, Rosicarelli B, Franciotta D, Magliozzi R, Reynolds R, Cinque P, et al.. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med 2007;204(12):2899-912. DOI 10.1084/jem.20071030.

61. Serafini B, Rosicarelli B, Veroni C, Mazzola GA, Aloisi F. Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism. Journal of Virology 2019;93(24). DOI 10.1128/jvi.00980-19.

62. Multiple Sclerosis between Genetics and Infections: Human Endogenous Retroviruses in Monocytes and Macrophages - Frontiers, accessed November 19, 2025, https://www.frontiersin.org/journals/immunology/articles/ 47/full

63. Perron H, Germi R, Bernard C, Garcia-Montojo M, Deluen C, Farinelli L, et al.. Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease. Mult Scler 2012;18(12):1721-36. DOI 10.1177/1352458512441381.

64. Li W, Lee MH, Henderson L, Tyagi R, Bachani M, Steiner J, et al.. Human endogenous retrovirus-K contributes to motor neuron disease. Sci Transl Med 2015;7(307):307ra153. DOI 10.1126/scitranslmed.aac8201.

65. Human Endogenous Retrovirus-K and TDP-43 Expression Bridges ALS and HIV Neuropathology - Frontiers, accessed November 19, 2025, https://www.frontiersin.org/journals/microbiology/articles/ 86/full

    Find this paper

66. Mielcarska MB, Rouse BT. Viruses and the Brain—A Relationship Prone to Trouble. Viruses 2025;17(2):203. DOI 10.3390/v17020203.

67. Ludlow M, Kortekaas J, Herden C, Hoffmann B, Tappe D, Trebst C, et al.. Neurotropic virus infections as the cause of immediate and delayed neuropathology. Acta Neuropathol 2016;131(2):159-184. DOI 10.1007/s00401-015-1511-3.

68. Broecker F, Moelling K. What viruses tell us about evolution and immunity: beyond Darwin?. Ann N Y Acad Sci 2019;1447(1):53-68. DOI 10.1111/nyas.14097.

69. Ancient Viruses Inadvertently Aided the Evolution of Primate Brains | American Scientist, accessed November 19, 2025, https://www.americanscientist.org/blog/from-the-staff/ancient-viruses-inadverte ntly-aided-the-evolution-of-primate-brains

70. Shirogane Y, Takemoto R, Suzuki T, Kameda T, Nakashima K, Hashiguchi T, et al.. CADM1 and CADM2 Trigger Neuropathogenic Measles Virus-Mediated Membrane Fusion by Acting in cis. J Virol 2021;95(14):e0052821. DOI 10.1128/JVI.00528-21.

71. Ai S, Klein RS. Update on T cells in the virally infected brain: friends and foes. Curr Opin Neurol 2020;33(3):405-412. DOI 10.1097/WCO.0000000000000825.

72. Nath A, Lee M, Henderson L, Bachani M, Steiner J, von Geldern G, et al.. Role of an Endogenous Retrovirus in ALS Pathophysiology and Effect of Anti-Retrovirals In Vitro (P5.203). Neurology 2016;86(16_supplement). DOI 10.1212/WNL.86.16_supplement.P5.203.

The Validity Ledger

The argument above is only as strong as its weakest load-bearing joint, and the reader is owed an explicit accounting of where it stands on the ground and where it stands on inference.